Elite Pharmaceuticals Inc (ELTP)
0.5177
-0.06
(-9.98%)
USD |
OTCM |
Nov 14, 16:00
Elite Pharmaceuticals Cash and Short Term Investments (Quarterly): 8.407M for June 30, 2024
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 8.407M |
| March 31, 2024 | 7.106M |
| December 31, 2023 | 5.816M |
| September 30, 2023 | 8.654M |
| June 30, 2023 | 9.077M |
| March 31, 2023 | 7.832M |
| December 31, 2022 | 17.91M |
| September 30, 2022 | 18.56M |
| June 30, 2022 | 19.78M |
| March 31, 2022 | 8.535M |
| December 31, 2021 | 7.288M |
| September 30, 2021 | 4.491M |
| June 30, 2021 | 4.751M |
| March 31, 2021 | 3.193M |
| December 31, 2020 | 5.413M |
| September 30, 2020 | 4.366M |
| June 30, 2020 | 2.788M |
| March 31, 2020 | 1.132M |
| December 31, 2019 | 1.870M |
| September 30, 2019 | 2.256M |
| June 30, 2019 | 2.577M |
| March 31, 2019 | 2.278M |
| December 31, 2018 | 3.681M |
| September 30, 2018 | 4.705M |
| June 30, 2018 | 5.644M |
| Date | Value |
|---|---|
| March 31, 2018 | 7.179M |
| December 31, 2017 | 7.244M |
| September 30, 2017 | 7.557M |
| June 30, 2017 | 9.573M |
| March 31, 2017 | 10.59M |
| December 31, 2016 | 13.28M |
| September 30, 2016 | 12.58M |
| June 30, 2016 | 12.82M |
| March 31, 2016 | 11.51M |
| December 31, 2015 | 8.103M |
| September 30, 2015 | 9.031M |
| June 30, 2015 | 11.62M |
| March 31, 2015 | 7.464M |
| December 31, 2014 | 8.274M |
| September 30, 2014 | 7.627M |
| June 30, 2014 | 8.173M |
| March 31, 2014 | 6.942M |
| December 31, 2013 | 1.081M |
| September 30, 2013 | 0.7662M |
| June 30, 2013 | 0.2311M |
| March 31, 2013 | 0.369M |
| December 31, 2012 | 0.0657M |
| September 30, 2012 | 0.2073M |
| June 30, 2012 | 0.4751M |
| March 31, 2012 | 0.6684M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
1.132M
Minimum
Mar 2020
19.78M
Maximum
Jun 2022
7.735M
Average
7.106M
Median
Mar 2024
Cash and Short Term Investments (Quarterly) Benchmarks
| Biomarin Pharmaceutical Inc | 930.44M |
| BioCardia Inc | 1.421M |
| Zevra Therapeutics Inc | 49.26M |
| Verrica Pharmaceuticals Inc | 22.96M |
| Terns Pharmaceuticals Inc | 225.30M |